Insulet recorded a 31.3% bottom-line slide on a sales increase of 28.8%. Adjusted to exclude one-time items, earnings per ...

Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Dexcom (NASDAQ:DXCM) announced today that it expanded its partnership with Oura, officially launching an integration with ...

(NYSE:SENS) shares dipped after hours today on first-quarter results that beat revenue projections on Wall Street.

Sequel Med Tech and Senseonics today announced a commercial development agreement to combine insulin delivery and glucose ...

Phillips Medisize announced that it officially integrated Vectura into its business, expanding its capabilities in inhaled ...

Medtronic (NYSE:MDT) announced today that it appointed Kate Cronin as the new chief marketing officer for its Diabetes unit.

IDE Group recently unveiled OKO, its new ophthalmic auto-injector for improving drug delivery precision and efficiency.

Abbott announced today that it entered a first-of-its-kind agreement to integrate data from its Libre systems into Epic EHR ...

Orchestra BioMed (Nasdaq:OBIO) announced that it received FDA investigational device exemption (IDE) for its Virtue ...

A judge has issued a permanent injunction, signaling an Insulet (Nasdaq:PODD) victory in a trade secret case against EOFlow.

Insulet announced today that its board of directors appointed Ashley McEvoy as president and CEO, effective immediately.